MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1038/bmt.2009.128

Медицинская библиотека · Bone marrow transplantation · 2009

Long-term outcome after allo-SCT: close follow-up on a large cohort treated with myeloablative regimens.

Abou-Mourad Y R, Lau B C, Barnett M J, Forrest D L, Hogge D E, Nantel S H, Nevill T J, Shepherd J D, Smith C A, Song K W, Sutherland H J, Toze C L, Lavoie J C

СтатьяПеревод в очереди

Аннотация

We analyzed the late outcomes of 429 long-term survivors post allogeneic hematopoietic SCT (allo-HSCT) who received transplant in our center between 1981 and 2002, and were free of their primary disease for > or =2 years after allo-HSCT. Late recurrent primary malignancy was found in 58 (13.5%) patients and was the primary cause of late death. A total of 37 (8.6%) patients died of non-relapse causes at a median of 5.5 years (range, 2-15.6 years) post allo-HSCT. The major non-relapse causes of death were chronic GVHD (cGVHD), secondary malignancy and infection. The probabilities of OS and EFS were 85% (95% cumulative incidence (CI) (81-89%)) and 79% (95% CI (74-83%)) at 10 years, respectively. Long-term allo-HSCT survivors were evaluated for late complications (median follow-up, 8.6 years (range, 2.3-22.8 years)). cGVHD was diagnosed in 196 (53.1%) survivors. The endocrine and metabolic complications were hypogonadism in 134 (36.3%) patients, osteopenia/osteoporosis in 90 (24.4%), dyslipidemia in 33 (8.9%), hypothyroidism in 28 (7.6%) and diabetes in 28 (7.6%). Hypertension was diagnosed in 79 (21.4%), renal impairment in 70 (19.0%), depression in 40 (10.8%) and sexual dysfunction in 33 (8.9%) survivors. We conclude that in patients who receive allo-HSCT as treatment for hematological malignancy and who are free of their original disease 2 years post transplant, mortality is low and the probability of durable remission is high. Lifelong surveillance is recommended.

Для цитирования: Abou-Mourad Y R, Lau B C, Barnett M J, Forrest D L, Hogge D E, Nantel S H, Nevill T J, Shepherd J D, Smith C A, Song K W, Sutherland H J, Toze C L, Lavoie J C. Long-term outcome after allo-SCT: close follow-up on a large cohort treated with myeloablative regimens.. Bone marrow transplantation. 2009. DOI: 10.1038/bmt.2009.128.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.